Edition:
United Kingdom

Neptune Technologies & Bioressources Inc (NEPT.OQ)

NEPT.OQ on NASDAQ Stock Exchange Capital Market

2.09USD
15 Dec 2017
Change (% chg)

$-0.04 (-1.88%)
Prev Close
$2.13
Open
$2.13
Day's High
$2.15
Day's Low
$2.03
Volume
188,650
Avg. Vol
90,421
52-wk High
$2.18
52-wk Low
$0.70

Chart for

About

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Neptune Technologies Extends Global Maxsimil Licence To Cannabis-Derived Products​

Nov 27 Neptune Technologies & Bioressources Inc :

27 Nov 2017

BRIEF-Neptune Q2 revenue C$6.8 million versus C$11.6 million

* Neptune Technologies & Bioressources Inc - ‍gain of $23.9 million realized from sale of Krill Oil business​

14 Nov 2017

BRIEF-Neptune reports about 45 pct fall in Q1 revenue

* Neptune Technologies & Bioressources Inc qtrly ‍net loss of $1.2 million versus net income of $1.3 million in prior year​

14 Aug 2017

BRIEF-Neptune appoints John Moretz as chairman

* Neptune announces resignation of Pierre Fitzgibbon as a director and the appointment of John Moretz as chairman

08 Aug 2017

BRIEF-Neptune receives Nasdaq notification regarding minimum bid requirements

* Neptune receives nasdaq notification regarding minimum bid requirements Source text for Eikon: Further company coverage:

27 Jul 2017

Earnings vs. Estimates